Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP4CO for Acute Vaso-occlusive Crises in Sickle Cell Disease
NCT01925001Phase 2Withdrawn
- Sponsor
- Sangart
- Start
- Oct 2013
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of mp4co in sickle cell disease (SCD), sponsored by Sangart. Planned start Oct 2013; status: withdrawn.
02
Drugs
mp4co
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01925001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01925001.